TORONTO, June 25, 2018 (GLOBE NEWSWIRE) — Invidx Corp. (“Invidx”), a company controlled by Lorna Samsoondar, the President and director of the Company, announces that it has disposed of 1,107,500 common shares of ChroMedX Corp. (the “Company” or “ChroMedX”) through the facilities of the Canadian Securities Exchange between December 27, 2017 and June 20, 2018. Prior to this disposition, Invidx held 20,474,552 common shares of ChroMedX.

There are currently approximately 101,177,362 common shares of ChroMedX issued and outstanding. Invidx has ownership over an aggregate of 19,367,052 common shares of the Company on an undiluted basis, representing 19.14% of the issued and outstanding common shares of the Company. Invidx does not own any convertible securities of the Company. Invidx disposed of the securities in the ordinary course and may make additional dispositions of securities of the Company, depending on price and general market conditions.

A copy of the Early Warning Report filed under applicable Canadian provincial securities legislation in connection with Invidx’s shareholdings in ChroMedX may be found at www.sedar.com under ChroMedX’s profile.

For more information, please contact:
Invidx Corp.
Telephone: 905-471-3930